{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:22:05Z","timestamp":1789683725823,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.wneu.2021.07.041","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:29:07Z","timestamp":1626481747000},"page":"e398-e405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Metastatic Renal Cell Carcinoma to the Spine: Outcomes and Morbidity: Single-Center Experience"],"prefix":"10.1016","volume":"154","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0439-0451","authenticated-orcid":false,"given":"Brian J.","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Noeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1130-3125","authenticated-orcid":false,"given":"Hesham","family":"Yasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3144-1306","authenticated-orcid":false,"given":"Patrick W.","family":"Hitchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2021.07.041_bib2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/CBM-2011-0176","article-title":"Renal cell carcinoma","volume":"9","author":"Cairns","year":"2010","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.wneu.2021.07.041_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3171\/spi.2001.94.1.0018","article-title":"Metastatic renal cell carcinoma of the spine: surgical treatment and results","volume":"94","author":"Jackson","year":"2001","journal-title":"Neurosurg Spine"},{"key":"10.1016\/j.wneu.2021.07.041_bib4","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1016\/j.wneu.2017.10.011","article-title":"Radiosurgery for treatment of renal cell metastases to spine: a systematic review of the literature","volume":"109","author":"Smith","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.041_bib5","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJM199609193351207","article-title":"Renal-cell carcinoma","volume":"335","author":"Motzer","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2021.07.041_bib6","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.3171\/2016.5.FOCUS16145","article-title":"Factors associated with improved survival following surgery for renal cell carcinoma spinal metastases","volume":"41","author":"Petteys","year":"2016","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.wneu.2021.07.041_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.22603\/ssrr.1.2016-0021","article-title":"Classification and scoring systems for metastatic spine tumors: a literature review","volume":"1","author":"Tokuhashi","year":"2017","journal-title":"Spine Surg Relat Res"},{"key":"10.1016\/j.wneu.2021.07.041_bib8","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1097\/01.brs.0000180401.06919.a5","article-title":"A\u00a0revised scoring system for preoperative evaluation of metastatic spine tumor prognosis","volume":"30","author":"Tokuhashi","year":"2005","journal-title":"Spine"},{"key":"10.1016\/j.wneu.2021.07.041_bib9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s10143-017-0935-8","article-title":"Surgical treatment of spinal metastases from renal cell carcinoma\u2014effects of preoperative embolization on intraoperative blood loss","volume":"41","author":"Reitz","year":"2018","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.wneu.2021.07.041_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00586-012-2648-6","article-title":"Outcome of embolised vascular metastatic renal cell tumours causing spinal cord compression","volume":"22","author":"Quraishi","year":"2013","journal-title":"Eur Spine J"},{"key":"10.1016\/j.wneu.2021.07.041_bib11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/2192568217737777","article-title":"The challenges of renal cell carcinoma metastatic to the spine: a systematic review of survival and treatment","volume":"8","author":"Goodwin","year":"2018","journal-title":"Glob Spine J"},{"key":"10.1016\/j.wneu.2021.07.041_bib12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00000478-198210000-00007","article-title":"Prognostic significance of morphologic parameters in renal cell carcinoma","volume":"6","author":"Fuhrman","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.wneu.2021.07.041_bib13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3171\/spi.2005.2.5.0564","article-title":"Surgical management of spinal metastases: analysis of prognostic factors during a 10-year experience","volume":"2","author":"North","year":"2005","journal-title":"J\u00a0Neurosurg Spine"},{"key":"10.1016\/j.wneu.2021.07.041_bib14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(05)66954-1","article-title":"Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial","volume":"366","author":"Patchell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.wneu.2021.07.041_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3171\/2013.9.SPINE13158","article-title":"Factors affecting survival in 267 consecutive patients undergoing surgery for spinal metastasis from renal cell carcinoma: clinical article","volume":"20","author":"Tatsui","year":"2014","journal-title":"J\u00a0Neurosurg Spine"},{"key":"10.1016\/j.wneu.2021.07.041_bib16","doi-asserted-by":"crossref","first-page":"e19838","DOI":"10.1097\/MD.0000000000019838","article-title":"Outcomes of patients with spinal metastases from renal cell carcinoma treated with conventionally fractionated external beam radiation therapy","volume":"99","author":"Lee","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.wneu.2021.07.041_bib17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ijrobp.2020.06.014","article-title":"Stereotactic ablative radiotherapy for \u2265t1b primary renal cell carcinoma: a report from the International Radiosurgery Oncology Consortium for Kidney (IROCK)","volume":"108","author":"Siva","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.wneu.2021.07.041_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.critrevonc.2018.02.017","article-title":"Treatment of spinal metastases in renal cell carcinoma: a critical review","volume":"125","author":"Teyssonneau","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.wneu.2021.07.041_bib19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ctrv.2011.06.011","article-title":"Skeletal metastasis in renal cell carcinoma: current and future management options","volume":"38","author":"Wood","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.wneu.2021.07.041_bib20","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00345-017-2078-5","article-title":"Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients","volume":"35","author":"Borgmann","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.wneu.2021.07.041_bib21","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.21037\/tau-20-1466","article-title":"The promising role of radiotherapy in the treatment of advanced or metastatic renal cell carcinoma: a narrative review","volume":"9","author":"Wei","year":"2020","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.wneu.2021.07.041_bib22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.5301\/tj.5000640","article-title":"Role of radiotherapy in the treatment of renal cell cancer: updated and critical review","volume":"103","author":"Fusco","year":"2017","journal-title":"Tumori"},{"key":"10.1016\/j.wneu.2021.07.041_bib23","first-page":"29","article-title":"Stereotactic body radiation therapy (SBRT) for metastatic renal cell carcinoma: a multi-institutional experience","volume":"7","author":"Singh","year":"2020","journal-title":"J\u00a0Radiosurgery SBRT"},{"key":"10.1016\/j.wneu.2021.07.041_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11060-014-1455-9","article-title":"Stereotactic radiosurgery compared with external radiation therapy as a primary treatment in spine metastasis from renal cell carcinoma: a multicenter, matched-pair study","volume":"119","author":"Sohn","year":"2014","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2021.07.041_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijrobp.2018.06.047","article-title":"Imaging-based outcomes for 24 Gy in 2 daily fractions for patients with de novo spinal metastases treated with spine stereotactic body radiation therapy (SBRT)","volume":"102","author":"Tseng","year":"2018","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.wneu.2021.07.041_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3171\/2020.6.SPINE20861","article-title":"Stereotactic body radiation therapy for spinal metastases: a novel local control stratification by spinal region","volume":"34","author":"Kowalchuk","year":"2021","journal-title":"J\u00a0Neurosurg Spine"},{"key":"10.1016\/j.wneu.2021.07.041_bib27","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3171\/2020.4.SPINE20118","article-title":"Hypofractionated spinal stereotactic body radiation therapy for high-grade epidural disease","volume":"33","author":"Rothrock","year":"2020","journal-title":"J\u00a0Neurosurg Spine"},{"issue":"suppl 1","key":"10.1016\/j.wneu.2021.07.041_bib28","first-page":"i25","article-title":"The importance of multidisciplinary care for spine metastases: initial tumor management","volume":"7","author":"Newman","year":"2020","journal-title":"Neurooncol Pract"},{"issue":"suppl","key":"10.1016\/j.wneu.2021.07.041_bib29","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1097\/BRS.0b013e3181bac4b2","article-title":"Shifting paradigms in the treatment of metastatic spine disease","volume":"34","author":"Bilsky","year":"2009","journal-title":"Spine"},{"key":"10.1016\/j.wneu.2021.07.041_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3171\/2012.11.SPINE12111","article-title":"Local disease control for spinal metastases following \u201cseparation surgery\u201d and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients: clinical article","volume":"18","author":"Laufer","year":"2013","journal-title":"J\u00a0Neurosurg Spine"},{"key":"10.1016\/j.wneu.2021.07.041_bib31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.nec.2017.05.006","article-title":"A\u00a0novel use of the intraoperative MRI for metastatic spine tumors: laser interstitial thermal therapy for percutaneous treatment of epidural metastatic spine disease","volume":"28","author":"Thomas","year":"2017","journal-title":"Neurosurg Clin N Am"},{"key":"10.1016\/j.wneu.2021.07.041_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.nec.2019.11.006","article-title":"Percutaneous hybrid therapy for spinal metastatic disease: laser interstitial thermal therapy and spinal stereotactic radiosurgery","volume":"31","author":"Vega","year":"2020","journal-title":"Neurosurg Clin N Am"},{"key":"10.1016\/j.wneu.2021.07.041_bib33","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.prro.2015.09.014","article-title":"The use of image guided laser interstitial thermotherapy to supplement spine stereotactic radiosurgery to manage metastatic epidural spinal cord compression: proof of concept and dosimetric analysis","volume":"6","author":"Ghia","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.wneu.2021.07.041_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2018.10.010","article-title":"Systemic treatment of metastatic clear cell renal cell carcinoma in 2018: current paradigms, use of immunotherapy, and future directions","volume":"75","author":"Lalani","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.wneu.2021.07.041_bib35","doi-asserted-by":"crossref","first-page":"154984","DOI":"10.1016\/j.cyto.2019.154984","article-title":"Interleukin-2 chronotherapy for metastatic renal cell carcinoma: results of a phase I-II study","volume":"128","author":"Re","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.wneu.2021.07.041_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2021.07.041_bib37","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1200\/JCO.2016.70.7398","article-title":"Cabozantinib versus sunitinib as initial targeted therapy for patients with metastatic renal cell carcinoma of poor or intermediate risk: the Alliance A031203 CABOSUN Trial","volume":"35","author":"Choueiri","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2021.07.041_bib38","doi-asserted-by":"crossref","DOI":"10.1007\/s11864-017-0458-0","article-title":"Checkpoint inhibitors for the treatment of renal cell carcinoma","volume":"18","author":"Ghatalia","year":"2017","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.wneu.2021.07.041_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21134691","article-title":"Immune checkpoint inhibitors in the treatment of renal cancer: current state and future perspective","volume":"21","author":"Lavacchi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.wneu.2021.07.041_bib40","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa1712126","article-title":"Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma","volume":"378","author":"Motzer","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2021.07.041_bib41","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa1816714","article-title":"Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma","volume":"380","author":"Rini","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2021.07.041_bib42","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.wneu.2020.08.006","article-title":"Neurologic complications of preoperative embolization of spinal metastasis: a systemic review of the literature identifying distinct mechanisms of injury","volume":"143","author":"Houten","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.041_bib43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1590\/s1808-185120181703193262","article-title":"Renal cell carcinoma metastasis of the spine: bleeding control methods","volume":"17","author":"Zaborovskii","year":"2018","journal-title":"Coluna\/Columna"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875021010366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875021010366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:05:31Z","timestamp":1761815131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875021010366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":42,"alternative-id":["S1878875021010366"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2021.07.041","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metastatic Renal Cell Carcinoma to the Spine: Outcomes and Morbidity: Single-Center Experience","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2021.07.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}